Assistant Professor of Clinical Pharmacy at The Ohio State University College of Pharmacy and an Advisor for State Government Affairs at the American Pharmacists Association
Strategies Necessary to Correct the Trajectory of US Pharmacy Deserts
While experts have been measuring the impacts stemming from US pharmacy deserts, they are also working to establish a path forward to reduce closures and increase access.
How the Rise in US Pharmacy Deserts Impacts Patients’ Health
When independent and retail storefronts close across the country, creating a lack of pharmacy services in the community, pharmacy deserts arise.
Why Pharmacy Deserts Are Detrimental to US Communities
Michael Murphy, PharmD, MBA, discusses the increasingly prominent impacts of pharmacy deserts, highlighting discrepancies in the term's definition and the financial pressures impacting sustainability.
Pharmacy Closures Limiting Access to Preventative Patient Care
With expertise into the growing issue of pharmacy deserts, Michael Murphy, PharmD, MBA, discussed exactly what patients are losing when their community no longer has pharmacy access.
Q&A: PBM Reform, Other Policy Considerations to Combat Pharmacy Deserts
Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.
Q&A: Pharmacy Desert Improvement Reliant on Industry Advocacy, Reform
Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.
Debates on Pharmacy Desert Definition Impact Access to Care
Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.